SURG.00153 Cardiac Contractility Modulation Therapy

This policy addresses cardiac contractility modulation (CCM) therapy, an implantable device-based treatment for heart failure. Anthem considers CCM investigational/experimental and not medically necessary; it is not covered for any indication, including heart failure. There are no covered exceptions or patient selection criteria—CCM is non-covered in all circumstances (claims may reference codes 00153, C1824, K1030).

"The use of cardiac contractility modulation therapy is consideredinvestigational and not medically necessaryfor all indications, including but not limited to heart failure."

Sign up to see full coverage criteria, indications, and limitations.